You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 47 Baseline blood DNA methylation-based immune profiles and tumor mutational burden predict survival outcomes in anti-PD-1 treated head and neck cancer patient

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
47 Baseline blood DNA methylation-based immune profiles and tumor mutational burden predict survival outcomes in anti-PD-1 treated head and neck cancer patient

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023222016
Dec 20237708
Jan 20242603
Feb 20244603
Mar 20244401
Apr 20243403
May 20242600
Jun 20245805
Jul 20242802
Aug 20241601
Sep 20245404
Oct 20241205
Nov 202456013
Dec 202460018
Jan 20252804
Feb 2025202
Mar 2025003
Apr 2025001
May 2025004
Jun 2025002
Total789098